Dalphene Labs
Deals, market moves, supply, and new products and approvals.
Industry, page 4
12345See more →
Industry
Hugel global botulinum toxin sales rise forty-six percent in H1 2026
Hugel Posts Record H1 Earnings as Global Toxin Sales Rise 46.6%

Industry
DermCare Management Acquires Wilmington Dermatology Center and Fort Worth Plastic Surgery
DermCare Management Acquires National Top-Tier Wilmington Dermatology Center

Industry
Medik8 launches Exo-PDRN serums to boost microneedling results and recovery
Medik8 Introduces Exo-PDRN Serum to Optimize Professional Microneedling and Post-Procedure Recovery

Industry
DermDox Group acquires Modern Aesthetics Plastic Surgery in Pennsylvania
DermDox Group Expands Mid-Atlantic Footprint with Modern Aesthetics Acquisition

Industry
Cynosure Lutronic showcases XERF skin tightening system at IMCAS Asia
Cynosure Lutronic Launches XERF RF System for Deep Dermal Tightening at IMCAS Asia

Industry
Health Canada clears Boey, the first serotype-E aesthetic neurotoxin
A short-acting, fast-onset toxin built on a brand new class gets its first green light anywhere.

Industry
Waldencast sells Obagi Medical to Bridgepoint for up to $460M
A practitioner-distributed skincare and filler brand changes private-equity hands as beauty and medical aesthetics keep converging.

Industry
ParagonCare acquires Haju Medical to expand Southeast Asian distribution
ParagonCare Acquires Haju Medical for A$70 Million, Consolidating K-Aesthetics Hub in Southeast Asia

Industry
Medytox wins China approval for Neuramis filler, launching as Filux
A Korean HA filler clears the NMPA, one more step in Korean supply pushing into China.

Industry
Medytox unit wins Korean approval for animal-free 200-unit toxin
A higher-dose, animal-component-free Korean toxin signals where lower-cost supply is heading.

Industry
Japan's aesthetics market: 1.22 million users, only 2% penetration
631 billion yen, growing, and chains take roughly half of what converts.

Industry
Korea's filler and device exports hit fresh record in May 2026
Filler and energy-device shipments surged into the US and Brazil as derm-led medical tourism set its own record.